Proton-Pump Inhibitor as Palliative Care for Chemotherapy-Induced Gastroesophageal Reflux Disease in Pancreatic Cancer Patients

被引:11
|
作者
Uwagawa, Tadashi [1 ]
Misawa, Takeyuki [1 ]
Iida, Tomonori [1 ]
Sakamoto, Taro [1 ]
Gocho, Takeshi [1 ]
Wakiyama, Shigeki [1 ]
Hirohara, Shoichi [1 ]
Yanaga, Katsuhiko [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan
关键词
RECOMMENDATIONS; GUIDELINES; THERAPY;
D O I
10.1089/jpm.2009.0404
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Relief of adverse events induced by chemotherapy is an important issue for patients, especially those with a poor prognosis, such as with pancreatic cancer. There are no reports of the relationship between gastroesophageal reflux disease (GERD) and chemotherapy, so we investigated the incidence of chemotherapy-induced GERD in patients undergoing treatment with gemcitabine or S-1 for pancreatic cancer and the effect of sodium rabeprazole (RPZ), a proton-pump inhibitor. GERD was diagnosed in 40% of the patients according to the Frequency Scale for Symptoms of GERD score, and RBZ therapy significantly improved their symptoms.
引用
收藏
页码:815 / 818
页数:4
相关论文
共 50 条
  • [21] Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors
    Valentin Becker
    Stefan Grotz
    Christoph Schlag
    Simon Nennstiel
    Analena Beitz
    Bernhard Haller
    Roland M Schmid
    Alexander Meining
    Monther Bajbouj
    World Journal of Gastroenterology, 2014, (14) : 4017 - 4024
  • [22] The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease
    Pace, Fabio
    Pace, Marina
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (04) : 423 - 427
  • [23] Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited
    Lada, Michal J.
    Nieman, Dylan R.
    Han, Michelle
    Timratana, Poochong
    Alsalahi, Omran
    Peyre, Christian G.
    Jones, Carolyn E.
    Watson, Thomas J.
    Peters, Jeffrey H.
    SURGERY, 2013, 154 (04) : 856 - 864
  • [24] Proton Pump Inhibitor Therapy in Chemotherapy-induced Pancreatitis
    Fettah, Ali
    Yarali, Nese
    Bayram, Cengiz
    Kirsaclioglu, Ceyda T.
    Tunc, Bahattin
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (08) : 660 - 661
  • [25] Long-term Efficacy of Proton-Pump Inhibitors in Japanese Elderly Patients with Gastroesophageal Reflux Disease
    Arakawa, Tetsuo
    Fujiwara, Yasuhiro
    Tominaga, Kazunari
    Watanabe, Toshio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S6 - S6
  • [26] Work productivity and response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease
    Wahlqvist, Peter
    Ducrotte, Philippe
    Jones, Roger
    Liker, Harley
    GASTROENTEROLOGY, 2007, 132 (04) : A350 - A350
  • [27] Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
    Shi, Yichao
    Li, Jianfeng
    Cai, Shuntian
    Zhao, Hong
    Zhao, Huijun
    Sun, Gang
    Yang, Yunsheng
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [28] The putative mechanisms for proton pump inhibitor's failure in patients with gastroesophageal reflux disease
    Fass, Ronnie
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 42 - 42
  • [29] Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review
    Miyazaki, Hirota
    Igarashi, Ataru
    Takeuchi, Toshihisa
    Teng, Lida
    Uda, Akihito
    Deguchi, Hisato
    Higuchi, Kazuhide
    Tango, Toshiro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (08) : 1316 - 1328
  • [30] Prospective Evaluation of Duodenogastroesophageal Reflux in Gastroesophageal Reflux Disease Patients Refractory to Proton Pump Inhibitor Therapy
    Kunsch, S.
    Neesse, A.
    Linhart, T.
    Nell, C.
    Gress, T. M.
    Ellenrieder, V.
    DIGESTION, 2012, 86 (04) : 315 - 322